Maharana Biswa Ranjan, Sudhakar Naduvanahalli Rajanna, Jawalagatti Vijayakumar, Saravanan Buddhi Chandrasekaran, Blake Damer P, Tewari Anup Kumar
Division of Parasitology, Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh 243122, India.
Department of Parasitology, Referral Veterinary Diagnostic & Extension Centre, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana 125001, India.
Vaccines (Basel). 2020 Feb 12;8(1):84. doi: 10.3390/vaccines8010084.
Trypanosomosis, caused by , is an economically significant disease of livestock. Systematic antigenic variation by the parasite has undermined prospects for the development of a protective vaccine that targets the immunodominant surface antigens, encouraging exploration of alternatives. The paraflagellar rod (PFR), constituent proteins of the flagellum, are prominent non-variable vaccine candidates for owing to their strategic location. Two major PFR constituent proteins, PFR1 (1770bp) and PFR2 (1800bp), were expressed using . Swiss albino mice were immunized with the purified recombinant TePFR1 (89KDa) and TePFR2 (88KDa) proteins, as well as with the mix of the combined proteins at equimolar concentrations, and subsequently challenged with virulent . The PFR-specific humoral response was assessed by ELISA. Cytometric bead-based assay was used to measure the cytokine response and flow cytometry for quantification of the cytokines. The recombinant TePFR proteins induced specific humoral responses in mice, including IgG1 followed by IgG2a and IgG2b. A balanced cytokine response induced by rTePFR 1 and 2 protein vaccination associated with extended survival and improved control of parasitemia following lethal challenge. The observation confirms the immunoprophylactic potential of the covert antigens of .
由[病原体名称未给出]引起的锥虫病是一种对家畜具有重要经济影响的疾病。该寄生虫的系统性抗原变异破坏了开发针对免疫显性表面抗原的保护性疫苗的前景,这促使人们探索替代方案。鞭毛旁杆(PFR)是鞭毛的组成蛋白,由于其战略位置,是[病原体名称未给出]突出的非可变疫苗候选物。使用[表达方法未给出]表达了两种主要的PFR组成蛋白,即PFR1(1770bp)和PFR2(1800bp)。用纯化的重组TePFR1(89KDa)和TePFR2(88KDa)蛋白以及等摩尔浓度的组合蛋白混合物对瑞士白化小鼠进行免疫,随后用强毒株[病原体名称未给出]进行攻击。通过ELISA评估PFR特异性体液反应。基于细胞计数微珠的测定法用于测量细胞因子反应,流式细胞术用于定量细胞因子。重组TePFR蛋白在小鼠中诱导了特异性体液反应,包括IgG1,随后是IgG2a和IgG2b。rTePFR 1和2蛋白疫苗接种诱导的平衡细胞因子反应与致死攻击后延长存活时间和改善寄生虫血症控制相关。该观察结果证实了[病原体名称未给出]隐蔽抗原的免疫预防潜力。